These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26921949)

  • 1. Production of Chemokine/Chemokine Receptor Complexes for Structural Biophysical Studies.
    Gustavsson M; Zheng Y; Handel TM
    Methods Enzymol; 2016; 570():233-60. PubMed ID: 26921949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
    Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
    J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.
    Gustavsson M; Dyer DP; Zhao C; Handel TM
    Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of ligand interaction with atypical chemokine receptor 3.
    Gustavsson M; Wang L; van Gils N; Stephens BS; Zhang P; Schall TJ; Yang S; Abagyan R; Chance MR; Kufareva I; Handel TM
    Nat Commun; 2017 Jan; 8():14135. PubMed ID: 28098154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.
    Wedemeyer MJ; Mahn SA; Getschman AE; Crawford KS; Peterson FC; Marchese A; McCorvy JD; Volkman BF
    J Biol Chem; 2020 Oct; 295(40):13927-13939. PubMed ID: 32788219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines.
    Hanes MS; Salanga CL; Chowdry AB; Comerford I; McColl SR; Kufareva I; Handel TM
    J Biol Chem; 2015 Sep; 290(37):22385-97. PubMed ID: 26216880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.
    Szpakowska M; Dupuis N; Baragli A; Counson M; Hanson J; Piette J; Chevigné A
    Biochem Pharmacol; 2016 Aug; 114():14-21. PubMed ID: 27238288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of chemokine (C-X-C motif) receptor four (CXCR4) at the fetal-maternal interface during early gestation in sheep: alterations in expression of chemokines, angiogenic factors and their receptors.
    Quinn KE; Prosser SZ; Kane KK; Ashley RL
    J Anim Sci; 2017 Mar; 95(3):1144-11153. PubMed ID: 28380526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal engineering of CXCL12 and CCL5 chemokines: functional characterization by electrophysiological recordings.
    Picciocchi A; Siaučiūnaiteė-Gaubard L; Petit-Hartlein I; Sadir R; Revilloud J; Caro L; Vivaudou M; Fieschi F; Moreau C; Vivès C
    PLoS One; 2014; 9(1):e87394. PubMed ID: 24498095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a chimeric chemokine as a specific ligand for ACKR3.
    Ameti R; Melgrati S; Radice E; Cameroni E; Hub E; Thelen S; Rot A; Thelen M
    J Leukoc Biol; 2018 Aug; 104(2):391-400. PubMed ID: 29601107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists.
    Szpakowska M; Meyrath M; Reynders N; Counson M; Hanson J; Steyaert J; Chevigné A
    Biochem Pharmacol; 2018 Jul; 153():299-309. PubMed ID: 29530506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilayer lipids modulate ligand binding to atypical chemokine receptor 3.
    Eberle SA; Gustavsson M
    Structure; 2024 Aug; 32(8):1174-1183.e5. PubMed ID: 38776922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II.
    Zhou N; Luo Z; Luo J; Hall JW; Huang Z
    Biochemistry; 2000 Apr; 39(13):3782-7. PubMed ID: 10736178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Color Luciferase Complementation for Chemokine Receptor Signaling.
    Luker KE; Luker GD
    Methods Enzymol; 2016; 570():119-29. PubMed ID: 26921944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of chemokines and chemokine receptors in brain tumor tissue derived cells.
    Razmkhah M; Arabpour F; Taghipour M; Mehrafshan A; Chenari N; Ghaderi A
    Asian Pac J Cancer Prev; 2014; 15(17):7201-5. PubMed ID: 25227814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QTY code designed thermostable and water-soluble chimeric chemokine receptors with tunable ligand affinity.
    Qing R; Han Q; Skuhersky M; Chung H; Badr M; Schubert T; Zhang S
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25668-25676. PubMed ID: 31776256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging.
    Montpas N; St-Onge G; Nama N; Rhainds D; Benredjem B; Girard M; Hickson G; Pons V; Heveker N
    J Biol Chem; 2018 Jan; 293(3):893-905. PubMed ID: 29180449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine.
    Qin L; Kufareva I; Holden LG; Wang C; Zheng Y; Zhao C; Fenalti G; Wu H; Han GW; Cherezov V; Abagyan R; Stevens RC; Handel TM
    Science; 2015 Mar; 347(6226):1117-22. PubMed ID: 25612609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3.
    Heuninck J; Perpiñá Viciano C; Işbilir A; Caspar B; Capoferri D; Briddon SJ; Durroux T; Hill SJ; Lohse MJ; Milligan G; Pin JP; Hoffmann C
    Mol Pharmacol; 2019 Dec; 96(6):778-793. PubMed ID: 31092552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.